The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design
Open accessAbstract
The benzene moiety is the most prevalent ring system in marketed drugs, underscoring its historic popularity in drug design either as a pharmacophore or as a scaffold that projects pharmacophoric elements. However, introspective analyses of medicinal chemistry practices at the beginning of the 21st century highlighted the indiscriminate deployment of phenyl rings as an important contributor to the poor physicochemical properties of advanced molecules, which limited their prospects of being developed into effective drugs. This Perspective deliberates on the design and applications of bioisosteric replacements for a phenyl ring that have provided practical solutions to a range of developability problems frequently encountered in lead optimization campaigns. While the effect of phenyl ring replacements on compound properties is contextual in nature, bioisosteric substitution can lead to enhanced potency, solubility, and metabolic stability while reducing lipophilicity, plasma protein binding, phospholipidosis potential, and inhibition of cytochrome P450 enzymes and the hERG channel.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Vitaku, E., Smith, D. T., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501100b · Cited by 6,418
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
Ruiz-Castillo, P., & Buchwald, S. L. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00512 · Cited by 2,936
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Self-citationFluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
Self-citationRings in Drugs: Miniperspective
Taylor, R. D., MacCoss, M., & Lawson, A. D. G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4017625 · Cited by 2,543
Sono, M., Roach, M. P., Coulter, E. D., & Dawson, J. H. (1996) · Chemical Reviews · doi:10.1021/cr9500500 · Cited by 2,441
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Common and Uncommon Cytochrome P450 Reactions Related to Metabolism and Chemical Toxicity
Guengerich, F. P. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002583 · Cited by 1,655
Aromatic Rings in Chemical and Biological Recognition: Energetics and Structures
Salonen, L. M., Ellermann, M., & Diederich, F. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007560 · Cited by 1,539
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Waring, M. J., Arrowsmith, J., Leach, A. R., Leeson, P. D., Mandrell, S., Owen, R. M., Pairaudeau, G., Pennie, W. D., Pickett, S. D., Wang, J., et al. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4609 · Cited by 1,450
Escape from Flatland 2: complexity and promiscuity
Lovering, F. (2013) · MedChemComm · doi:10.1039/c2md20347b · Cited by 1,444
Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug
Capdeville, R., Buchdunger, E., Zimmermann, J., & Matter, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd839 · Cited by 1,389
Bioisosterism: A Rational Approach in Drug Design
Patani, G. A., & LaVoie, E. J. (1996) · Chemical Reviews · doi:10.1021/cr950066q · Cited by 1,328
Aromatic substituent constants for structure-activity correlations
Hansch, C., Leo, A., Unger, S. H., Kim, K. H., Nikaitani, D., & Lien, E. J. (1973) · Journal of Medicinal Chemistry · doi:10.1021/jm00269a003 · Cited by 1,262
gem-Disubstituent Effect: Theoretical Basis and Synthetic Applications
Jung, M. E., & Piizzi, G. (2005) · Chemical Reviews · doi:10.1021/cr940337h · Cited by 903
Ritchie, T. J., & Macdonald, S. J. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.014 · Cited by 901
Late-stage C–H functionalization offers new opportunities in drug discovery
Guillemard, L., Kaplaneris, N., Ackermann, L., & Johansson, M. J. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00300-6 · Cited by 837
A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design
Beno, B. R., Yeung, K.-S., Bartberger, M. D., Pennington, L. D., & Meanwell, N. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501853m · Cited by 772
Self-citationDiscovery of a Covalent Inhibitor of KRAS G12C (AMG 510) for the Treatment of Solid Tumors
Lanman, B. A., Allen, J. R., Allen, J. G., Amegadzie, A. K., Ashton, K. S., Booker, S. K., Chen, J. J., Chen, N., Frohn, M. J., Goodman, G., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01180 · Cited by 765
Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex
Tan, Q., Zhu, Y., Li, J., Chen, Z., Han, G. W., Kufareva, I., Li, T., Ma, L., Fenalti, G., Li, J., et al. (2013) · Science · doi:10.1126/science.1241475 · Cited by 712
The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives
Wanka, L., Iqbal, K., & Schreiner, P. R. (2013) · Chemical Reviews · doi:10.1021/cr100264t · Cited by 696
The importance of synthetic chemistry in the pharmaceutical industry
Campos, K. R., Coleman, P. J., Alvarez, J. C., Dreher, S. D., Garbaccio, R. M., Terrett, N. K., Tillyer, R. D., Truppo, M. D., & Parmee, E. R. (2019) · Science · doi:10.1126/science.aat0805 · Cited by 668
Molecular Recognition in Chemical and Biological Systems
Persch, E., Dumele, O., & Diederich, F. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201408487 · Cited by 654
Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017—Utility and Limitations
Baell, J. B., & Nissink, J. W. M. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00903 · Cited by 648
Ishikawa, M., & Hashimoto, Y. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101356p · Cited by 619
Saturated bioisosteres of benzene: where to go next?
Mykhailiuk, P. K. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob02812e · Cited by 613
A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs
Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M., & Leeson, P. D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021053p · Cited by 546
Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects
Bolton, J. L., & Dunlap, T. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00256 · Cited by 522
Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings
Dalvie, D. K., Kalgutkar, A. S., Khojasteh-Bakht, S. C., Obach, R. S., & O'Donnell, J. P. (2002) · Chemical Research in Toxicology · doi:10.1021/tx015574b · Cited by 518
Do enthalpy and entropy distinguish first in class from best in class?
Freire, E. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.005 · Cited by 491
Put a ring on it: application of small aliphatic rings in medicinal chemistry
Bauer, M. R., Di Fruscia, P., Lucas, S. C. C., Michaelides, I. N., Nelson, J. E., Storer, R. I., & Whitehurst, B. C. (2021) · RSC Medicinal Chemistry · doi:10.1039/d0md00370k · Cited by 479
Stepan, A. F., Subramanyam, C., Efremov, I. V., Dutra, J. K., O’Sullivan, T. J., DiRico, K. J., McDonald, W. S., Won, A., Dorff, P. H., Nolan, C. E., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300094u · Cited by 468
Cryo-EM in drug discovery: achievements, limitations and prospects
Renaud, J.-P., Chari, A., Ciferri, C., Liu, W.-T., Rémigy, H.-W., Stark, H., & Wiesmann, C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.77 · Cited by 461
Utilization of operational schemes for analog synthesis in drug design
Topliss, J. G. (1972) · Journal of Medicinal Chemistry · doi:10.1021/jm00280a002 · Cited by 457
The State of the Art in Azaborine Chemistry: New Synthetic Methods and Applications
Giustra, Z. X., & Liu, S.-Y. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b09446 · Cited by 456
Complex reactions catalyzed by cytochrome P450 enzymes
Isin, E. M., & Guengerich, F. P. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.07.003 · Cited by 448
Ritchie, T. J., Macdonald, S. J. F., Young, R. J., & Pickett, S. D. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.11.014 · Cited by 442
Fsp3: A new parameter for drug-likeness
Wei, W., Cherukupalli, S., Jing, L., Liu, X., & Zhan, P. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.017 · Cited by 421
The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization
Pennington, L. D., & Moustakas, D. T. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01807 · Cited by 408
Two‐ and Three‐dimensional Rings in Drugs
Aldeghi, M., Malhotra, S., Selwood, D. L., & Chan, A. W. E. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12260 · Cited by 372
Chemistry and Biology of Resveratrol-Derived Natural Products
Keylor, M. H., Matsuura, B. S., & Stephenson, C. R. J. (2015) · Chemical Reviews · doi:10.1021/cr500689b · Cited by 366
The protein data bank: A computer-based archival file for macromolecular structures
Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., & Tasumi, M. (1978) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(78)90204-7 · Cited by 359
Beyond ferryl-mediated hydroxylation: 40 years of the rebound mechanism and C–H activation
Huang, X., & Groves, J. T. (2017) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-016-1414-3 · Cited by 356
Lipophilic Efficiency as an Important Metric in Drug Design
Johnson, T. W., Gallego, R. A., & Edwards, M. P. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00077 · Cited by 349
Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury
Proctor, W. R., Foster, A. J., Vogt, J., Summers, C., Middleton, B., Pilling, M. A., Shienson, D., Kijanska, M., Ströbel, S., Kelm, J. M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2002-1 · Cited by 328
Time-Related Differences in the Physical Property Profiles of Oral Drugs
Leeson, P. D., & Davis, A. M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049717d · Cited by 326
Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist
Ahuja, S., Mukund, S., Deng, L., Khakh, K., Chang, E., Ho, H., Shriver, S., Young, C., Lin, S., Johnson, J. P., et al. (2015) · Science · doi:10.1126/science.aac5464 · Cited by 319
Young, R. J., Green, D. V. S., Luscombe, C. N., & Hill, A. P. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.06.001 · Cited by 311
Impact of Cross-Coupling Reactions in Drug Discovery and Development
Buskes, M. J., & Blanco, M.-J. (2020) · Molecules · doi:10.3390/molecules25153493 · Cited by 296
Protein X-ray Crystallography and Drug Discovery
Maveyraud, L., & Mourey, L. (2020) · Molecules · doi:10.3390/molecules25051030 · Cited by 269
Locke, G. M., Bernhard, S. S. R., & Senge, M. O. (2019) · Chemistry – A European Journal · doi:10.1002/chem.201804225 · Cited by 261
Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity
Hill, A. P., & Young, R. J. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.05.016 · Cited by 258
Investigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLA 2 Inhibitor
Measom, N. D., Down, K. D., Hirst, D. J., Jamieson, C., Manas, E. S., Patel, V. K., & Somers, D. O. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00281 · Cited by 253
Pharmaceuticals that contain polycyclic hydrocarbon scaffolds
Stockdale, T. P., & Williams, C. M. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00477a · Cited by 250
Meanwell, N. A. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00043 · Cited by 239
Self-citationCombinatorial compound libraries for drug discovery: an ongoing challenge
Mario Geysen, H., Schoenen, F., Wagner, D., & Wagner, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1035 · Cited by 224
A manual method for applying the Hansch approach to drug design
Topliss, J. G. (1977) · Journal of Medicinal Chemistry · doi:10.1021/jm00214a001 · Cited by 222
Liu, G., Link, J. T., Pei, Z., Reilly, E. B., Leitza, S. T., Nguyen, B., Marsh, K. C., Okasinski, G. F., von Geldern, T. W., Ormes, M., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0002782 · Cited by 220
Recent Developments in Azaborinine Chemistry
Bélanger‐Chabot, G., Braunschweig, H., & Roy, D. K. (2017) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201700562 · Cited by 220
Bak, A., Gore, A., Yanez, E., Stanton, M., Tufekcic, S., Syed, R., Akrami, A., Rose, M., Surapaneni, S., Bostick, T., et al. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21280 · Cited by 218
Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor
Rosenquist, Å., Samuelsson, B., Johansson, P.-O., Cummings, M. D., Lenz, O., Raboisson, P., Simmen, K., Vendeville, S., de Kock, H., Nilsson, M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401507s · Cited by 213
Aguilar, A., Lu, J., Liu, L., Du, D., Bernard, D., McEachern, D., Przybranowski, S., Li, X., Luo, R., Wen, B., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01665 · Cited by 211
An overview of FDA-approved new molecular entities: 1827–2013
Kinch, M. S., Haynesworth, A., Kinch, S. L., & Hoyer, D. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.018 · Cited by 210
Pellicciari, R., Raimondo, M., Marinozzi, M., Natalini, B., Costantino, G., & Thomsen, C. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960254o · Cited by 202
Discovery of a Highly Potent and Selective MEK Inhibitor: GSK1120212 (JTP-74057 DMSO Solvate)
Abe, H., Kikuchi, S., Hayakawa, K., Iida, T., Nagahashi, N., Maeda, K., Sakamoto, J., Matsumoto, N., Miura, T., Matsumura, K., et al. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200004g · Cited by 196
Toxicology Strategies for Drug Discovery: Present and Future
Blomme, E. A. G., & Will, Y. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00407 · Cited by 194
Tomassini, J., Selnick, H., Davies, M. E., Armstrong, M. E., Baldwin, J., Bourgeois, M., Hastings, J., Hazuda, D., Lewis, J., & McClements, W. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.12.2827 · Cited by 188
Validating Eaton's Hypothesis: Cubane as a Benzene Bioisostere
Chalmers, B. A., Xing, H., Houston, S., Clark, C., Ghassabian, S., Kuo, A., Cao, B., Reitsma, A., Murray, C. P., Stok, J. E., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510675 · Cited by 186
Kim, Y.-C., Ji, X.-D., Melman, N., Linden, J., & Jacobson, K. A. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990421v · Cited by 176
Acetylene Group, Friend or Foe in Medicinal Chemistry
Talele, T. T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01617 · Cited by 176
Designing around Structural Alerts in Drug Discovery
Kalgutkar, A. S. S. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00917 · Cited by 173
Kowalinski, E., Zubieta, C., Wolkerstorfer, A., Szolar, O. H. J., Ruigrok, R. W. H., & Cusack, S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002831 · Cited by 169
Tse, E. G., Houston, S. D., Williams, C. M., Savage, G. P., Rendina, L. M., Hallyburton, I., Anderson, M., Sharma, R., Walker, G. S., Obach, R. S., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00746 · Cited by 166
Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors
Galli, U., Travelli, C., Massarotti, A., Fakhfouri, G., Rahimian, R., Tron, G. C., & Genazzani, A. A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4001049 · Cited by 162
Molecular Property Design: Does Everyone Get It?
Leeson, P. D., & Young, R. J. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00157 · Cited by 162
Pyridones in drug discovery: Recent advances
Zhang, Y., & Pike, A. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.127849 · Cited by 162
Wood, A., & Armour, D. (2005) · Progress in Medicinal Chemistry · doi:10.1016/s0079-6468(05)43007-6 · Cited by 161
Caravella, J. A., Lin, J., Diebold, R. B., Campbell, A.-M., Ericsson, A. M., Gustafson, G. R., Wang, Z., Castro, J., Clarke, A., Gotur, D., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01423 · Cited by 161
Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor
Wang, L., Doherty, G. A., Judd, A. S., Tao, Z., Hansen, T. M., Frey, R. R., Song, X., Bruncko, M., Kunzer, A. R., Wang, X., et al. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00568 · Cited by 161
Cumming, J. N., Smith, E. M., Wang, L., Misiaszek, J., Durkin, J., Pan, J., Iserloh, U., Wu, Y., Zhu, Z., Strickland, C., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.02.013 · Cited by 160
Cubanes in Medicinal Chemistry
Reekie, T. A., Williams, C. M., Rendina, L. M., & Kassiou, M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00888 · Cited by 160
A history of the roles of cytochrome P450 enzymes in the toxicity of drugs
Guengerich, F. P. (2020) · Toxicological Research · doi:10.1007/s43188-020-00056-z · Cited by 149
Analysis of Benzenoid Substitution Patterns in Small Molecule Active Pharmaceutical Ingredients
Nilova, A., Campeau, L., Sherer, E. C., & Stuart, D. R. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00915 · Cited by 147
Li, P., Terrett, J. A., & Zbieg, J. R. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00436 · Cited by 147
Raboisson, P., de Kock, H., Rosenquist, Å., Nilsson, M., Oden, L. S., Lin, T., Roue, N., Ivanov, V., Wähling, H., Wickström, K., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.088 · Cited by 145
Maaß, P. C., Schulz‐Gasch, T., Ståhl, M., & Rarey, M. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci060094h · Cited by 141
Solid-Phase Synthesis of Biologically Active Benzoannelated Nitrogen Heterocycles: An Update
Gil, C., & Bräse, S. (2008) · Journal of Combinatorial Chemistry · doi:10.1021/cc800102t · Cited by 138
Cheung, A. K., Hurley, B., Kerrigan, R., Shu, L., Chin, D. N., Shen, Y., O’Brien, G., Sung, M. J., Hou, Y., Axford, J., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01291 · Cited by 134
Bridge Functionalisation of Bicyclo[1.1.1]pentane Derivatives
Anderson, J. M., Measom, N. D., Murphy, J. A., & Poole, D. L. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202106352 · Cited by 133
COMPOUNDS DESIGNED TO FIT A SITE OF KNOWN STRUCTURE IN HUMAN HAEMOGLOBIN
Beddell, C. R., Goodford, P. J., Norrington, F. E. A., Wilkinson, S., & Wootton, R. (1976) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1976.tb07468.x · Cited by 132
Zhao, J., Chang, Y., He, C., Burke, B. J., Collins, M. R., Bel, M. D., Elleraas, J., Gallego, G. M., Montgomery, T. P., Mousseau, J. J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2108881118 · Cited by 131
The evolution of synthetic oral drug properties
Proudfoot, J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.024 · Cited by 129
Medicinal Chemistry Profiling of Monocyclic 1,2‐Azaborines
Zhao, P., Nettleton, D. O., Karki, R. G., Zécri, F. J., & Liu, S. (2017) · ChemMedChem · doi:10.1002/cmdc.201700047 · Cited by 129
A Real-World Perspective on Molecular Design
Kuhn, B., Guba, W., Hert, J., Banner, D. W., Bissantz, C., Ceccarelli, S., Haap, W. J., Körner, M., Kuglstatter, A., Lerner, C., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01875 · Cited by 126
Goh, Y. L., Cui, Y. T., Pendharkar, V. V., & Adsool, V. A. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00018 · Cited by 124
Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations
Young, R. J., & Leeson, P. D. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00180 · Cited by 121
Barlaam, B. C., Casella, R., Cidado, J. R., Cook, C., Savi, C. D., Dishington, A. P., Donald, C. S., Drew, L., Ferguson, A. D., Ferguson, D., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01754 · Cited by 121
Dragovich, P. S., Prins, T. J., Zhou, R., Johnson, T., Hua, Y., Luu, H. T., Sakata, S. K. L., Brown, E. L., Maldonado, F. C., Tuntland, T., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030166l · Cited by 114
Assessing the lipophilicity of fragments and early hits
Mortenson, P. N., & Murray, C. W. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9435-z · Cited by 112
Wager, T. T., Pettersen, B. A., Schmidt, A. W., Spracklin, D. K., Mente, S., Butler, T. W., Howard, H. R., Lettiere, D. J., Rubitski, D. M., Wong, D. F., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200939b · Cited by 111
Côté, B., Burch, J. D., Asante‐Appiah, E., Bayly, C., Bedard, L. L., Blouin, M., Campeau, L., Cauchon, E., Chan, M., Chefson, A., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.070 · Cited by 108
The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations
Shultz, M. D. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.030 · Cited by 105
Phospholipidosis as a Function of Basicity, Lipophilicity, and Volume of Distribution of Compounds
Hanumegowda, U., Wenke, G., Regueiro‐Ren, A., Yordanova, R., Corradi, J., & Adams, S. P. (2010) · Chemical Research in Toxicology · doi:10.1021/tx9003825 · Cited by 105
Protein Crystallography and Computer Graphics—toward Rational Drug Design
Hol, W. G. J. (1986) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198607673 · Cited by 104
Benzazaborinines as Novel Bioisosteric Replacements of Naphthalene: Propranolol as an Example
Rombouts, F. J. R., Tovar, F., Austin, N. E., Tresadern, G., & Trabanco, A. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01088 · Cited by 101
Meanwell, N. A. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_29 · Cited by 100
Self-citationDrug discovery in the era of cryo-electron microscopy
Robertson, M. J., Meyerowitz, J., & Skiniotis, G. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.06.008 · Cited by 95
Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim
Su, L., Wang, Y., Wang, J., Mifune, Y., Morin, M. D., Jones, B. T., Moresco, E. M. Y., Boger, D. L., Beutler, B., & Zhang, H. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01583 · Cited by 95
Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole
Ohwada, J., Tsukazaki, M., Hayase, T., Oikawa, N., Isshiki, Y., Fukuda, H., Mizuguchi, E., Sakaitani, M., Shiratori, Y., Yamazaki, T., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00892-2 · Cited by 92
Providing a New Aniline Bioisostere through the Photochemical Production of 1-Aminonorbornanes
Staveness, D., Sodano, T. M., Li, K., Burnham, E. A., Jackson, K. D., & Stephenson, C. R. J. (2018) · Chem · doi:10.1016/j.chempr.2018.10.017 · Cited by 92
Identification of Influenza Endonuclease Inhibitors Using a Novel Fluorescence Polarization Assay
Baughman, B. M., Slavish, P. J., DuBois, R. M., Boyd, V. A., White, S. W., & Webb, T. R. (2012) · ACS Chemical Biology · doi:10.1021/cb200439z · Cited by 87
Group Efficiency: A Guideline for Hits‐to‐Leads Chemistry
Verdonk, M. L., & Rees, D. C. (2008) · ChemMedChem · doi:10.1002/cmdc.200800132 · Cited by 87
Ripa, L., Edman, K., Dearman, M. S., Edenro, G., Hendrickx, R., Ullah, V., Chang, H., Lepistö, M., Chapman, D., Geschwindner, S., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01690 · Cited by 87
Pu, Q., Zhang, H., Guo, L., Cheng, M. M., Doty, A. C., Ferguson, H. M., Fradera, X., Lesburg, C. A., McGowan, M. A., Miller, J. R., et al. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00195 · Cited by 87
Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients
Gampe, C. M., & Verma, V. A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01177 · Cited by 86
Shamovsky, I. L., Ripa, L., Börjesson, L., Mee, C. D., Nordén, B., Hansen, P., Hasselgren, C., O'Donovan, M. R., & Sjö, P. (2011) · Journal of the American Chemical Society · doi:10.1021/ja206427u · Cited by 84
Aguilar, A., Sun, W., Liu, L., Lu, J., McEachern, D., Bernard, D., Deschamps, J. R., & Wang, S. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501541j · Cited by 83
Houston, S. D., Fahrenhorst‐Jones, T., Xing, H., Chalmers, B. A., Sykes, M. L., Stok, J. E., Soto, C. F., Burns, J. M., Bernhardt, P. V., Voss, J. J. D., et al. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob01238a · Cited by 82
Discovery of a potent and selective small molecule hGPR91 antagonist
Bhuniya, D., Umrani, D., Dave, B., Salunke, D., Kukreja, G., Gundu, J., Naykodi, M., Shaikh, N. S., Shitole, P., Kurhade, S., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.04.091 · Cited by 80
The Evolving Landscape of Heterocycles in Drugs and Drug Candidates
Zhang, T. Y. (2016) · Advances in heterocyclic chemistry · doi:10.1016/bs.aihch.2016.05.001 · Cited by 78
Wu, Y., & Meanwell, N. A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00790 · Cited by 77
Self-citationA Synopsis of the Properties and Applications of Heteroaromatic Rings in Medicinal Chemistry
Meanwell, N. A. (2017) · Advances in heterocyclic chemistry · doi:10.1016/bs.aihch.2016.11.002 · Cited by 76
Self-citationWang, H.-L., Katon, J. G., Chenera, B., Bannon, A. W., Bernard, C., Doherty, E. M., Dominguez, C., Gavva, N. R., Gore, V., Ma, V., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070191h · Cited by 73
Brown, A. D., Brown, T. B., Calabrese, A. A., Ellis, D. J., Puhalo, N., Ralph, M. J., & Watson, L. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.097 · Cited by 73
Recent Advances and Outlook for the Isosteric Replacement of Anilines
Sodano, T. M., Combee, L. A., & Stephenson, C. R. J. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00687 · Cited by 73
Schnider, P., Bissantz, C., Bruns, A., Dolente, C., Goetschi, E., Jakob‐Roetne, R., Künnecke, B., Mueggler, T., Muster, W., Parrott, N. J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01478 · Cited by 72
Mattei, P., Boehringer, M., Giorgio, P. D., Fischer, H., Hennig, M., Huwyler, J., Koçer, B., Kuhn, B., Loeffler, B. M., MacDonald, A., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.024 · Cited by 71
Brown, D. G., Gagnon, M. M., & Boström, J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501894t · Cited by 70
Cooper, D. R., Porebski, P. J., Chruszcz, M., & Minor, W. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.585154 · Cited by 68
Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists
Morin, M. D., Wang, Y., Jones, B. T., Mifune, Y., Su, L., Shi, H., Moresco, E. M. Y., Zhang, H., Beutler, B., & Boger, D. L. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b09223 · Cited by 67
Brooks, C. A., Barton, L. S., Behm, D. J., Eidam, H. S., Fox, R. M., Hammond, M., Hoang, T. H., Holt, D. A., Hilfiker, M. A., Lawhorn, B. G., et al. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00274 · Cited by 65
Rowland, A., van Dyk, M., Mangoni, A. A., Miners, J. O., McKinnon, R. A., Wiese, M. D., Rowland, A., Kichenadasse, G., Gurney, H., & Sorich, M. J. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1229303 · Cited by 64
Furazans in Medicinal Chemistry
Mancini, R. S., Barden, C., Weaver, D. F., & Reed, M. A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01901 · Cited by 60
Fauber, B. P., René, O., Boenig, G. D. L., Burton, B., Deng, Y., Eidenschenk, C., Everett, C., Gobbi, A., Hymowitz, S. G., Johnson, A. R., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.06.048 · Cited by 59
Conformational Design Principles in Total Synthesis
Chen, R., Shen, Y., Yang, S., & Zhang, Y. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202003735 · Cited by 58
Liang, J., Zhang, B., Labadie, S. S., Ortwine, D. F., Vinogradova, M. V., Kiefer, J. R., Gehling, V. S., Harmange, J.-C., Cummings, R. T., Lai, T., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.06.078 · Cited by 55
Positional Analogue Scanning: An Effective Strategy for Multiparameter Optimization in Drug Design
Pennington, L. D., Aquila, B. M., Choi, Y., Valiulin, R. A., & Muegge, I. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02092 · Cited by 55
Claesson, A., & Minidis, A. B. E. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00046 · Cited by 53
Wang, Y., Zhao, H., Brewer, J. T., Li, H., Lao, Y., Amberg, W., Behl, B., Akritopoulou‐Zanze, I., Dietrich, J. D., Lange, U. E. W., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00295 · Cited by 53
Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi
Brand, S., Ko, E. J., Viayna, E., Thompson, S., Spinks, D., Thomas, M. G., Sandberg, L., Francisco, A. F., Jayawardhana, S., Smith, V. C., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00463 · Cited by 49
Knöpfel, T. F., Furet, P., Mah, R., Buschmann, N., Leblanc, C., Ripoche, S., Graus-Porta, D., Wartmann, M., Galuba, I., & Fairhurst, R. A. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00485 · Cited by 49
Aromatic Rings as Molecular Determinants for the Molecular Recognition of Protein Kinase Inhibitors
Zhu, Y., Alqahtani, S. M., & Hu, X. (2021) · Molecules · doi:10.3390/molecules26061776 · Cited by 47
PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease
Gopalsamy, A., AULABAUGH, A. E., Barakat, A., Beaumont, K. C., Cabral, S., Canterbury, D. P., Casimiro‐Garcia, A., Chang, J. S., Chen, M. Z., Choi, C., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01518 · Cited by 45
Potent and Orally Bioavailable 8-Bicyclo[2.2.2]octylxanthines as Adenosine A1 Receptor Antagonists
Kiesman, W. F., Zhao, J. X., Conlon, P. R., Dowling, J. E., Petter, R. C., Lutterodt, F., Jin, X., Smits, G. J., Fure, M., Jayaraj, A. A., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0605381 · Cited by 43
Fragment-based discovery and optimization of BACE1 inhibitors
Madden, J., Dod, J. R., Godemann, R., Kraemer, J., Smith, M., Biniszkiewicz, M., Hallett, D. J., Barker, J. J., Dyekjær, J. D., & Hesterkamp, T. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.089 · Cited by 42
Scaffold mining of kinase hinge binders in crystal structure database
Xing, L., Rai, B., & Lunney, E. A. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-013-9700-4 · Cited by 41
Ma, B., Bohnert, T., Otipoby, K. L., Tien, E. S., Arefayene, M., Bai, J., Bajrami, B., Bame, E., Chan, T. R., Humora, M. J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00702 · Cited by 40
Hall, A., Chanteux, H., Ménochet, K., Ledecq, M., & Schulze, M. E. D. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02245 · Cited by 40
Cyclooctatetraene: A Bioactive Cubane Paradigm Complement
Xing, H., Houston, S. D., Chen, X., Ghassabian, S., Fahrenhorst‐Jones, T., Kuo, A., Murray, C. P., Conn, K., Jaeschke, K. N., Jin, D., et al. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201806277 · Cited by 38
McKerrall, S. J., Nguyen, T. T., Lai, K. W., Bergeron, P., Deng, L., DiPasquale, A. G., Chang, J. H., Chen, J., Chernov-Rogan, T., Hackos, D. H., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00141 · Cited by 38
Bonazzi, S., Goold, C. P., Gray, A. J., Thomsen, N. M., Nunez, J., Karki, R. G., Gorde, A., Biag, J. D., Malik, H. A., Sun, Y., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01398 · Cited by 37
Holistic drug design for multiparameter optimization in modern small molecule drug discovery
Pennington, L. D., & Muegge, I. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128003 · Cited by 37
Nakahata, T., Tokumaru, K., Ito, Y., Ishii, N., Setoh, M., Shimizu, Y., Harasawa, T., Aoyama, K., Hamada, T., Kori, M., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.02.005 · Cited by 35
Furukawa, H., Miyamoto, Y., Hirata, Y., Watanabe, K., Hitomi, Y., Yoshitomi, Y., Aida, J., Noguchi, N., Takakura, N., Takami, K., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00843 · Cited by 35
4-Methyl-5-phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I
Zhu, Y., Olson, S. H., Hermanowski‐Vosatka, A., Mundt, S. S., Shah, K., Springer, M. S., Thieringer, R., Wright, S. D., Xiao, J., Zokian, H. J., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.04.013 · Cited by 34
The Emerging Utility of Co-Crystals in Drug Discovery and Development
Meanwell, N. A. (2008) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)00022-5 · Cited by 33
Self-citationIsavuconazonium sulfate: a triazole prodrug for invasive fungal infections
Murrell, D. E., Bossaer, J. B., Carico, R. “., Harirforoosh, S., & Cluck, D. B. (2016) · International Journal of Pharmacy Practice · doi:10.1111/ijpp.12302 · Cited by 33
Discovery of Second Generation RORγ Inhibitors Composed of an Azole Scaffold
Kotoku, M., Maeba, T., Fujioka, S., Yokota, M., Seki, N., Ito, K., Suwa, Y., Ikenogami, T., Hirata, K., Hase, Y., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01567 · Cited by 33
Zhang, H., Lapointe, B. T., Anthony, N. J., Azevedo, R., Cals, J., Correll, C. C., Daniels, M. H., Deshmukh, S. V., van Eenenaam, H., Ferguson, H. M., et al. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00431 · Cited by 29
Pissot‐Soldermann, C., Simić, O., Renatus, M., Erbel, P. J. A., Melkko, S., Wartmann, M., Bigaud, M., Weiss, A., McSheehy, P. M. J., Endres, R., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01245 · Cited by 29
Biaryl substituted hydantoin compounds as TACE inhibitors
Yu, W., Tong, L., Kim, S. H., Wong, M., Chen, L., Yang, D., Shankar, B. B., Lavey, B. J., Zhou, G., Kosinski, A., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.134 · Cited by 28
Dossetter, A. G., Douglas, A., & O'Donnell, C. (2012) · MedChemComm · doi:10.1039/c2md20155k · Cited by 28
Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 Agonists
Shi, J., Gu, Z., Jurica, E. A., Wu, X., Haque, L., Williams, K. N., Hernández, A. S., Hong, Z., Gao, Q., Dabros, M., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00982 · Cited by 28
Ravindra, M. P., Wilson, M. R., Tong, N., O’Connor, C. E., Karim, M. A., Polin, L., Wallace-Povirk, A., White, K., Kushner, J., Hou, Z., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00408 · Cited by 28
Discovery of a GPR40 Superagonist: The Impact of Aryl Propionic Acid α-Fluorination
Huang, H., Meegalla, S. K., Lanter, J. C., Winters, M. P., Zhao, S., Littrell, J. B., Qi, J., Rady, B., Lee, P. S., Liu, J., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00444 · Cited by 28
Zhang, X., Lei, Y., Hu, T., Wu, Y., Li, Z., Jiang, Z., Yang, C., Zhang, L., & You, Q. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01161 · Cited by 27
Discovery of DS-1971a, a Potent, Selective NaV1.7 Inhibitor
Shinozuka, T., Kobayashi, H., Suzuki, S. T., Tanaka, K., Karanjule, N. S., Hayashi, N., Tsuda, T., Tokumaru, E., Inoue, M., Ueda, K., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00259 · Cited by 26
Piemontese, L., Fracchiolla, G., Carrieri, A., Parente, M., Laghezza, A., Carbonara, G., Sblano, S., Tauro, M., Gilardi, F., Tortorella, P., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.044 · Cited by 25
Crawford, J. J., Kenny, P. W., Bowyer, J., Cook, C., Finlayson, J., Heyes, C., Highton, A. J., Hudson, J. A., Jestel, A., Krapp, S., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301119s · Cited by 24
Discovery and SAR of diarylsulfide cyclopropylamide LFA-1/ICAM-1 interaction antagonists
Link, J. T., Sorensen, B. K., Liu, G., Pei, Z., Reilly, E. B., Leitza, S. T., & Okasinski, G. F. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00105-6 · Cited by 23
Washburn, W. N., Manfredi, M. C., Devasthale, P. V., Zhao, G., Ahmad, S., Hernández, A. S., Robl, J. A., Wang, W., Mignone, J., Wang, Z., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500026w · Cited by 23
Ratni, H., Baumann, K., Bellotti, P., Cook, X. A. F., Green, L. G., Luebbers, T., Reutlinger, M., Stepan, A. F., & Vifian, W. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00043h · Cited by 23
Yusuff, N., Dore, M., Joud, C., Visser, M., Springer, C., Xie, X., Herlihy, K. M., PORTER, D. A., & Touré, B. B. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300095a · Cited by 21
Press, N. J., Taylor, R., Fullerton, J. D., TRANTER, P. R., McCarthy, C., Keller, T. H., Arnold, N., Beer, D., Brown, L., Cheung, R., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00902 · Cited by 20
Bioactivation of Trimethoprim to Protein-Reactive Metabolites in Human Liver Microsomes
Goldman, J. L., Koen, Y. M., Rogers, S. A., Li, K., Leeder, J. S., & Hanzlik, R. P. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.072041 · Cited by 20
Palacios, D. S., Meredith, E. L., Kawanami, T., Adams, C. M., Chen, X., Darsigny, V., Geno, E., Palermo, M. G., Baird, D., Boynton, G., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.12.037 · Cited by 20
Strategies to Mitigate the Bioactivation of Aryl Amines
Zhang, C., Crawford, J. J., Landry, M. L., Chen, H., Kenny, J. R., Khojasteh, S. C., Lee, W., Ma, S., & Young, W. B. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00138 · Cited by 20
Swidorski, J. J., Jenkins, S., Hanumegowda, U., Parker, D. D., Beno, B. R., Protack, T., Ng, A., Gupta, A., Shanmugam, Y., Dicker, I. B., et al. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.127823 · Cited by 20
Self-citationWinneroski, L. L., Erickson, J. A., Green, S. J., López, J. E., Stout, S. L., Porter, W. J., Timm, D. E., Audia, J. E., Barberis, M., Beck, J. P., et al. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115194 · Cited by 19
Axford, J., Sung, M. J., Manchester, J. I., Chin, D. N., Jain, M., Shin, Y., Dix, I., Hamann, L. G., Cheung, A. K., Sivasankaran, R., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02173 · Cited by 18
Piperazine Oxadiazole Inhibitors of Acetyl-CoA Carboxylase
Bourbeau, M. P., Siegmund, A., Allen, J. G., Shu, H., Fotsch, C. H., Bartberger, M. D., Kim, K., Komorowski, R., Graham, M., Busby, J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401601s · Cited by 17
Yang, M. G., Xiao, Z., Cherney, R. J., Tebben, A. J., Batt, D. G., Brown, G. D., Chen, J., Cvijic, M. E., Dabros, M., Duncia, J. V., et al. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00439 · Cited by 17
Palacios, D. S., Meredith, E. L., Kawanami, T., Adams, C. M., Chen, X., Darsigny, V., Palermo, M. G., Baird, D., George, E. L., Guy, C. T., et al. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00325 · Cited by 16
Patel, M., Cianci, C., Allard, C. W., Parker, D. D., Simmermacher, J., Jenkins, S., McAuliffe, B. V., Minassian, B., Discotto, L. F., Krystal, M., et al. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127516 · Cited by 15
Self-citationSubstituted phenyl triazoles as selective inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1
Sun, W., Maletic, M. M., Mundt, S. S., Shah, K., Zokian, H. J., Lyons, K., Waddell, S. T., & Balkovec, J. M. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.125 · Cited by 14
Liu, P., Wang, L., DuBois, B. G., Colandrea, V. J., Liu, R., Cai, J., Du, X., Quan, W., Morris, W., Bai, J., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00274 · Cited by 14
Ravindra, M. P., Wallace-Povirk, A., Karim, M. A., Wilson, M. R., O’Connor, C. E., White, K., Kushner, J., Polin, L., George, C., Hou, Z., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01708 · Cited by 13
Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists
Park, E. J., Ahn, Y., Jung, S., Bang, H., Kim, M., Hong, D. J., Kim, J., Suh, K. H., Kim, Y. J., Kim, D., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.07.026 · Cited by 13
Kazmierski, W. M., Baskaran, S., Walker, J. T., Miriyala, N., Meesala, R., Beesu, M., Adjabeng, G. M., Grimes, R. M., Hamatake, R. K., Leivers, M. R., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02176 · Cited by 10
Meanwell, N. A., & Sistla, R. K. (2020) · Advances in heterocyclic chemistry · doi:10.1016/bs.aihch.2020.10.004 · Cited by 9
Self-citationDiscovery of New Heterocyclic Ring Systems as Novel and Potent V1A Receptor Antagonists
Baska, F., Szántó, G., Bozó, É., Szakács, Z., Dékány, M., Kordás, K. S., Domány-Kovács, K., Kurkó, D., Hodoscsek, B., Magdó, I., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00486 · Cited by 8
Cited by
Bicyclobutanes: from curiosities to versatile reagents and covalent warheads
Kelly, C. B., Milligan, J. A., Tilley, L. J., & Sodano, T. M. (2022) · Chemical Science · doi:10.1039/d2sc03948f · Cited by 334
Bellotti, P., & Glorius, F. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c08206 · Cited by 294
Three-dimensional saturated C(sp3)-rich bioisosteres for benzene
Tsien, J., Hu, C., Merchant, R. R., & Qin, T. (2024) · Nature Reviews Chemistry · doi:10.1038/s41570-024-00623-0 · Cited by 263
Metadata
- Authors
- Subbaiah, M. A. M., & Meanwell, N. A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-09-30
- Volume
- 64
- Issue
- 19
- Pages
- 14046-14128
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3203279400
- Cited by
- 710
- References
- 194
- FWCI
- 42.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.